Genomic Health, Inc. (GHDX) Tops Q2 EPS by 8cm, Offers Q3 Rev. Guidance
Tweet Send to a Friend
Genomic Health, Inc. (NASDAQ: GHDX) reported Q2 EPS of $0.06, $0.08 better than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
